John Dyett

Director/Board Member at MEDLEY MANAGEMENT INC.

56 year

Finance

Health Technology

Consumer Services

Profile

John Hathaway Dyett is the founder of Spectrix Therapeutics LLC, which was founded in 2016.
He is also the founder of Salem Partners LLC, which was founded in 1997.
At Salem Partners LLC, he currently holds the title of Co-Chief Executive Officer.
In his current positions, Mr. Dyett is the Co-Chief Executive Officer at Salem Partners Wealth Management LLC since 2004.
He is also an Independent Director at Medley Management, Inc. since 2020, and a Director at OncoNano Medicine, Inc. Mr. Dyett has held former positions as an Independent Non-Executive Director at Femasys, Inc. from 2017 to 2023.
He was also a Director at Sebacia, Inc., a Trustee at Middlesex School, and an Independent Trustee at Sierra Total Return Fund from 2016 to 2020.
Mr. Dyett completed his undergraduate degree at Harvard University.

John Dyett active positions

Companies	Position	Start
MEDLEY MANAGEMENT INC.	Director/Board Member	2020-08-10
Salem Partners LLC Salem Partners LLC Investment Banks/BrokersFinance Operates as an investment bank and wealth management firm	Founder	1996-12-31
OncoNano Medicine, Inc. OncoNano Medicine, Inc. BiotechnologyHealth Technology Operates as a clinical-stage oncology company that develops proprietary nanotechnology platform for cancer therapeutics	Director/Board Member	-
Salem Partners Wealth Management LLC Salem Partners Wealth Management LLC Investment ManagersFinance Provides investment advice	Chief Executive Officer	2003-12-31

All active positions of John Dyett

Former positions of John Dyett

Companies	Position	End
FEMASYS INC.	Director/Board Member	2023-06-13
Sierra Total Return Fund Sierra Total Return Fund Investment Trusts/Mutual FundsMiscellaneous Acts as Closed-End Investment Fund/Investment Trust	Director/Board Member	2019-12-31
Spectrix Therapeutics LLC Spectrix Therapeutics LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes pharmaceutical products	Founder	2016-01-01
Sebacia, Inc. Sebacia, Inc. BiotechnologyHealth Technology Develops novel technology to treat acne	Director/Board Member	-
Middlesex School Middlesex School Other Consumer ServicesConsumer Services Functions as a College/University	Director/Board Member	-

See the detail of John Dyett's experience

Training of John Dyett

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of John Dyett's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	10
Salem Partners LLC Salem Partners LLC Investment Banks/BrokersFinance Operates as an investment bank and wealth management firm	Finance
Femasys, Inc. Femasys, Inc. Electronic Equipment/InstrumentsElectronic Technology Operates as a medical device company that focuses on women''s healthcare	Electronic Technology
Sebacia, Inc. Sebacia, Inc. BiotechnologyHealth Technology Develops novel technology to treat acne	Health Technology
Medley Management, Inc. Medley Management, Inc. Investment ManagersFinance Operates as an investment firm	Finance
Harvard University Harvard University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Middlesex School Middlesex School Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Salem Partners Wealth Management LLC Salem Partners Wealth Management LLC Investment ManagersFinance Provides investment advice	Finance
Sierra Total Return Fund Sierra Total Return Fund Investment Trusts/Mutual FundsMiscellaneous Acts as Closed-End Investment Fund/Investment Trust	Miscellaneous
Spectrix Therapeutics LLC Spectrix Therapeutics LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes pharmaceutical products	Health Technology
OncoNano Medicine, Inc. OncoNano Medicine, Inc. BiotechnologyHealth Technology Operates as a clinical-stage oncology company that develops proprietary nanotechnology platform for cancer therapeutics	Health Technology

See company connections